Health Payer Intelligence: Increasing Competition Can Reduce Prescription Drug Prices

Health Payer Intelligence: Increasing Competition Can Reduce Prescription Drug Prices

Reducing prescription drug prices for payers requires market-based solutions that increase competition and deregulate federal drug policies, PCMA wrote in a letter to HHS secretary Tom Price.